Specialist in internal disease, diabetology and clinical pharmacology.
Major publications:
Kosmalski M. et al. Diabetes mellitus in patients using psychotropic medications: How does it work?, Postępy Higieny i Medycyny Doświadczalnej, 2021, 75, s.398-405.
Kosmalski M et al. The coincidence of diabetes mellitus and asthma, their probable causal relationships and therapeutic opportunities, Advances in Respiratory Medicine, 2020, 88, 6, s.590-598.
Luzak B et al. Fibrinogen Glycation and Presence of Glucose Impair Fibrin Polymerization-An In Vitro Study of Isolated Fibrinogen and Plasma From Patients With Diabetes Mellitus, Biomolecules, 2020, 10, 6, s.1-24.
Przygodzki T et al. Diabetes and hyperglycemia affect platelet GPIIIa expression. Effects on adhesion potential of blood platelets from diabetic patients under in vitro flow conditions, International Journal of Molecular Sciences, 2020, 21, s.1-20.
Kosmalski M et al. Changes in the immune system - the key to diagnostics and therapy of patients with non-alcoholic fatty liver disease, Central European Journal of Immunology, 2018, 43, 2, s.231-239.
Kosmalski M et al. Relationship between ultrasound features of nonalcoholic fatty liver disease and cardiometabolic risk factors in patients with newly diagnosed type 2 diabetes, Polskie Archiwum Medycyny Wewnętrznej, 2013, 123, 9, s.436-441.
Specialist in internal disease, diabetology and clinical pharmacology.
Major publications:
Kosmalski M. et al. Diabetes mellitus in patients using psychotropic medications: How does it work?, Postępy Higieny i Medycyny Doświadczalnej, 2021, 75, s.398-405.
Kosmalski M et al. The coincidence of diabetes mellitus and asthma, their probable causal relationships and therapeutic opportunities, Advances in Respiratory Medicine, 2020, 88, 6, s.590-598.
Luzak B et al. Fibrinogen Glycation and Presence of Glucose Impair Fibrin Polymerization-An In Vitro Study of Isolated Fibrinogen and Plasma From Patients With Diabetes Mellitus, Biomolecules, 2020, 10, 6, s.1-24.
Przygodzki T et al. Diabetes and hyperglycemia affect platelet GPIIIa expression. Effects on adhesion potential of blood platelets from diabetic patients under in vitro flow conditions, International Journal of Molecular Sciences, 2020, 21, s.1-20.
Kosmalski M et al. Changes in the immune system - the key to diagnostics and therapy of patients with non-alcoholic fatty liver disease, Central European Journal of Immunology, 2018, 43, 2, s.231-239.
Kosmalski M et al. Relationship between ultrasound features of nonalcoholic fatty liver disease and cardiometabolic risk factors in patients with newly diagnosed type 2 diabetes, Polskie Archiwum Medycyny Wewnętrznej, 2013, 123, 9, s.436-441.